Noticeably, we recently highlighted a role for deregulated amounts of IL-6 in contributing to the alteration of local and systemic redox signalling markers in DMD patients and dystrophic mice [27, 28]. This evidence concerns the gene IL6 and Duchenne muscular dystrophy.